Denali Therapeutics (DNLI) Revenue (2018 - 2023)
Denali Therapeutics (DNLI) reported Revenue of $1.3 million for Q3 2023, up 588.59% year-over-year from $184000.0 in Q3 2022, and down 99.57% on a QoQ basis from $294.1 million in Q2 2023.
Denali Therapeutics (DNLI) has 6 years of Revenue data on file, last reported at $1.3 million in Q3 2023.
- Quarterly Revenue rose 588.59% year-over-year to $1.3 million in Q3 2023, while the trailing twelve-month figure through Jun 2024 was $1.3 million (down 99.63% YoY) and the FY2023 annual result came in at $330.5 million, up 9627.22% from the prior year.
- Revenue eased to $1.3 million in Q3 2023 per DNLI's latest filing, from $294.1 million in the prior quarter.
- Across five years, Revenue topped out at $316.8 million in Q4 2020 and bottomed at $1000.0 in Q1 2021.
- The 5-year median for Revenue is $5.3 million (2021), against an average of $42.1 million.
- The widest annual swing landed in 2020, when Revenue slumped 98.76%; it then surged 4214000.0% in 2022.
- Tracing DNLI's Revenue over 5 years: stood at $4.7 million in 2019, then surged by 6681.14% to $316.8 million in 2020, then slumped by 96.05% to $12.5 million in 2021, then retreated by 20.09% to $10.0 million in 2022, then plunged by 87.33% to $1.3 million in 2023.
- Per Business Quant, the three latest DNLI Revenue figures stand at $1.3 million (Q3 2023), $294.1 million (Q2 2023), and $35.1 million (Q1 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 306.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 2.99 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.61 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.17 Bn |
| 10 | Denali Therapeutics | 3.82 Bn | 3.82 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 1.27 Mn |
| Jun 30, 2023 | 294.12 Mn |
| Mar 31, 2023 | 35.14 Mn |
| Dec 31, 2022 | 10.00 Mn |
| Sep 30, 2022 | 184,000.00 |
| Jun 30, 2022 | 52.48 Mn |
| Mar 31, 2022 | 42.14 Mn |
| Dec 31, 2021 | 12.51 Mn |
| Sep 30, 2021 | 5.29 Mn |
| Jun 30, 2021 | 15.00 Mn |
| Mar 31, 2021 | 1,000.00 |
| Dec 31, 2020 | 316.82 Mn |
| Sep 30, 2020 | 5,000.00 |
| Jun 30, 2020 | 5.85 Mn |
| Mar 31, 2020 | 52,000.00 |
| Dec 31, 2019 | 4.67 Mn |
| Sep 30, 2019 | 96,000.00 |
| Jun 30, 2019 | 99,000.00 |
| Mar 31, 2019 | 4.21 Mn |
| Dec 31, 2018 | 125.62 Mn |
| Sep 30, 2018 | 1.20 Mn |
| Jun 30, 2018 | 1.65 Mn |
| Mar 31, 2018 | 641,000.00 |